SCHEMBL6808166

SCHEMBL6808166

Nc1cccc2cc(OS(=O)(=O)C(F)(F)F)ccc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 3/20 0.43
CA2 P00918 3/20 0.43
CA9 Q16790 2/20 0.42
HTR1A P08908 3/20 0.41
HTR1D P28221 3/20 0.41
HTR1B P28222 3/20 0.41
HSD17B10 Q99714 2/20 0.40
CYP2C9 P11712 1/20 0.40
ATIC P31939 1/20 0.40
CYP2C19 P33261 1/20 0.40
ALDH1A1 P00352 2/20 0.39
HPGD P15428 2/20 0.39
CYP3A4 P08684 1/20 0.39
TSHR P16473 1/20 0.39
KEAP1 Q14145 1/20 0.39
GAA P10253 2/20 0.38
RCE1 Q9Y256 2/20 0.38
HSD11B1 P28845 1/20 0.38
ADORA2A P29274 1/20 0.38
ADORA1 P30542 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL34471894 1.00 CA1 (0.43) CA1CA2CA9HTR1AHTR1D
SCHEMBL7358534 0.88 HTR1A (0.44) CA1CA2CA9HTR1AHTR1D
SCHEMBL30380710 0.88 HTR1A (0.44) CA1CA2CA9HTR1AHTR1D
SCHEMBL3110652 0.83 HTR1A (0.42) CA1CA2CA9HTR1AHTR1D
SCHEMBL6808137 0.82 HTR1D (0.41) CA1CA2CA9HTR1AHTR1D
SCHEMBL7755613 0.81 CA1 (0.45) CA1CA2CA9HSD17B10CYP2C9
SCHEMBL2605467 0.79 PPARG (0.41) CA1CA2CA9HTR1AHTR1D
SCHEMBL30203278 0.79 ALDH1A1 (0.44) CA1CA2HSD17B10ALDH1A1HPGD
SCHEMBL6101788 0.79 ALDH1A1 (0.44) CA1CA2HSD17B10ALDH1A1HPGD
SCHEMBL12074737 0.79 PPARG (0.40) CA1CA2CA9HTR1AHTR1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010124845-A1 PESTICIDAL ARYLPYRROLIDINES BAYER CROPSCIENCE AG (DE) 2010-11-04 WO disclosed
US-20040122001-A1 Pharmaceutical compounds ELI LILLY AND COMPANY 2004-06-24 US disclosed
EP-1345930-A2 PHARMACEUTICAL COMPOUNDS ELI LILLY AND COMPANY (US) 2003-09-24 EP disclosed
WO-2002050067-A2 PHARMACEUTICAL HETEROCYCLIC COMPOUNDS ELI LILLY AND COMPANY (US) 2002-06-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040122001-A1 Pharmaceutical compounds CYP2D6, LPXN, CYP1B1 CA1 3616/4885CA2 2335/4885CA9 916/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.